Two Sigma Investments
VIR icon

Two Sigma Investments’s Vir Biotechnology VIR Stock Holding History

Two Sigma Investments’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.9M Buy
1,439,494
+849,933
+144% +$6.77M 0.01% 1241
2025
Q4 		$3.56M Sell
589,561
-59,739
-9% -$356K 0.01% 2012
2025
Q3 		$3.71M Buy
649,300
+279,685
+76% +$1.43M 0.01% 1698
2025
Q2 		$1.86M Buy
369,615
+97,080
+36% +$520K ﹤0.01% 1884
2025
Q1 		$1.77M Buy
272,535
+26,659
+11% +$237K ﹤0.01% 1816
2024
Q4 		$1.8M Sell
245,876
-30,148
-11% -$238K ﹤0.01% 1791
2024
Q3 		$2.07M Sell
276,024
-80,521
-23% -$699K ﹤0.01% 1661
2024
Q2 		$3.17M Buy
356,545
+291,033
+444% +$2.79M 0.01% 1244
2024
Q1 		$664K Buy
65,512
+7,000
+12% +$71.3K ﹤0.01% 2199
2023
Q4 		$589K Buy
58,512
+36,912
+171% +$337K ﹤0.01% 2369
2023
Q3 		$202K Sell
21,600
-34,701
-62% -$495K ﹤0.01% 2638
2023
Q2 		$1.38M Buy
56,301
+15,314
+37% +$385K ﹤0.01% 1753
2023
Q1 		$954K Buy
40,987
+22,287
+119% +$570K ﹤0.01% 1890
2022
Q4 		$473K Buy
+18,700
New +$458K ﹤0.01% 2048
2021
Q3 		– Sell
-26,300
Closed -$1.24M – 4752
2021
Q2 		$1.24M Buy
+26,300
New +$1.2M ﹤0.01% 2290

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Two Sigma Investments's VIR Position: Q1 2026 in Review

Two Sigma Investments increased its Vir Biotechnology (VIR) stake by 144% in Q1 2026, buying an estimated $6.77M and bringing the position to 1,439,494 shares worth $12.9M. The position accounts for 0.01% of the portfolio, ranked #1241.

Two Sigma Investments first reported a position in VIR in Q2 2021 and has held it in 15 quarters since. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Two Sigma Investments held 1,439,494 shares of Vir Biotechnology worth $12.9M as of Q1 2026.
  • Two Sigma Investments bought 849,933 Vir Biotechnology shares in Q1 2026, an estimated $6.77M.
  • Vir Biotechnology made up 0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1241 holding.
  • Two Sigma Investments first reported a position in Vir Biotechnology in Q2 2021 and has held it in 15 quarters since.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.